Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian Corvese currently holds 50,053 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Corvese has been a net neutral trader of INKT stock. They have purchased $0 and sold $0 worth of shares.
Brian Corvese's most recent insider trade was on Dec 1, 2025, when they sold 1,612 shares at $11.09 per share.
Brian Corvese serves as Executive at MiNK Therapeutics, Inc. (INKT). They have executed 17 insider transactions totaling $0 over their tenure at the company.
Brian Corvese holds the position of Executive at MiNK Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Brian Corvese has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Brian Corvese was on Mar 25, 2024, when they purchased $76.1K worth of PTIX shares. This transaction involved 43,750 shares at $1.74 per share.
Brian Corvese currently owns 50,053 shares of MiNK Therapeutics, Inc. (INKT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian Corvese's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian Corvese has 17 Form 4 filings on record as an insider at MiNK Therapeutics, Inc..
Set alerts for Brian Corvese and 40,000+ other insiders.